Higher Fecal Short-Chain Fatty Acid Levels Are Associated with Gut Microbiome Dysbiosis, Obesity, Hypertension and Cardiometabolic Disease Risk Factors
Open accessThe DOI matches its Crossref record; 54 of the 55 references it cites were found in a registry or an index.
Abstract
Fiber fermentation by gut microbiota yields short-chain fatty acids (SCFAs) that are either absorbed by the gut or excreted in feces. Studies are conflicting as to whether SCFAs are beneficial or detrimental to cardiometabolic health, and how gut microbiota associated with SCFAs is unclear. In this study of 441 community-dwelling adults, we examined associations of fecal SCFAs, gut microbiota diversity and composition, gut permeability, and cardiometabolic outcomes, including obesity and hypertension. We assessed fecal microbiota by 16S rRNA gene sequencing, and SCFA concentrations by gas chromatography/mass spectrometry. Fecal SCFA concentrations were inversely associated with microbiota diversity, and 70 unique microbial taxa were differentially associated with at least one SCFA (acetate, butyrate or propionate). Higher SCFA concentrations were associated with a measure of gut permeability, markers of metabolic dysregulation, obesity and hypertension. Microbial diversity showed association with these outcomes in the opposite direction. Associations were significant after adjusting for measured confounders. In conclusion, higher SCFA excretion was associated with evidence of gut dysbiosis, gut permeability, excess adiposity, and cardiometabolic risk factors. Studies assessing both fecal and circulating SCFAs are needed to test the hypothesis that the association of higher fecal SCFAs with obesity and cardiometabolic dysregulation is due to less efficient SCFA absorption.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures



Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Million, M., Angelakis, E., Maraninchi, M., Henry, M., Giorgi, R., Valero, R., Vialettes, B., & Raoult, D. (2013) · International Journal of Obesity · doi:10.1038/ijo.2013.20 · Cited by 362
RetractedSchloss, P. D., Westcott, S. L., Ryabin, T., Hall, J. R., Hartmann, M., Hollister, E. B., Lesniewski, R. A., Oakley, B. B., Parks, D. H., Robinson, C. J., et al. (2009) · Applied and Environmental Microbiology · doi:10.1128/aem.01541-09 · Cited by 19,549 · cited 1×
“36 [22] following its standard operating procedure available November 2015.”
MethodAn obesity-associated gut microbiome with increased capacity for energy harvest
Turnbaugh, P. J., Ley, R. E., Mahowald, M. A., Magrini, V., Mardis, E. R., & Gordon, J. I. (2006) · Nature · doi:10.1038/nature05414 · Cited by 12,444 · cited 1×
“, homozygous for a mutation in the leptin gene (ob/ob) that produces a stereotyped, fully penetrant obesity phenotype) compared to their lean siblings (ob/+ and +/+) have a gut microbiome composition that promotes obesity through excess SCFA production and increased energy availability [14].”
BackgroundStructure, function and diversity of the healthy human microbiome
The Human Microbiome Project Consortium (2012) · Nature · doi:10.1038/nature11234 · Cited by 11,726
Greengenes, a Chimera-Checked 16S rRNA Gene Database and Workbench Compatible with ARB
DeSantis, T. Z., Hugenholtz, P., Larsen, N., Rojas, M., Brodie, E. L., Keller, K., Huber, T., Dalevi, D., Hu, P., & Andersen, G. L. (2006) · Applied and Environmental Microbiology · doi:10.1128/aem.03006-05 · Cited by 10,891 · cited 1×
“OTUs delimited at 97% identity were generated and classified using Greengenes 13_8_99 [23].”
MethodA core gut microbiome in obese and lean twins
Turnbaugh, P. J., Hamady, M., Yatsunenko, T., Cantarel, B. L., Duncan, A., Ley, R. E., Sogin, M. L., Jones, W. J., Roe, B. A., Affourtit, J. P., et al. (2009) · Nature · doi:10.1038/nature07540 · Cited by 7,823 · cited 1×
“, acetyl/propionyl-CoA carboxylase and acetyl-CoA carboxylase) [17].”
Metabolic Endotoxemia Initiates Obesity and Insulin Resistance
Cani, P. D., Amar, J., Iglesias, M. A., Poggi, M., Knauf, C., Bastelica, D., Neyrinck, A. M., Fava, F., Tuohy, K. M., Chabo, C., et al. (2007) · Diabetes · doi:10.2337/db06-1491 · Cited by 6,638 · cited 1×
“LBP is a biomarker of bacterial-derived LPS translocation from the gut to the periphery and higher serum LBP levels are thought to reflect gut permeability [43] and metabolic endotoxemia [44].”
BackgroundThe Microbial Metabolites, Short-Chain Fatty Acids, Regulate Colonic T reg Cell Homeostasis
Smith, P. M., Howitt, M. R., Panikov, N., Michaud, M., Gallini, C. A., Bohlooly-Y, M., Glickman, J. N., & Garrett, W. S. (2013) · Science · doi:10.1126/science.1241165 · Cited by 5,413 · cited 1×
“SCFAs may also be involved in appetite regulation [9], and play a role in gut and peripheral immune responses [10]; inducing the differentiation of T-regulatory cells [11].”
BackgroundCani, P. D., Bibiloni, R., Knauf, C., Waget, A., Neyrinck, A. M., Delzenne, N. M., & Burcelin, R. (2008) · Diabetes · doi:10.2337/db07-1403 · Cited by 4,819
Cross-talk between Akkermansia muciniphila and intestinal epithelium controls diet-induced obesity
Everard, A., Belzer, C., Geurts, L., Ouwerkerk, J. P., Druart, C., Bindels, L. B., Guiot, Y., Derrien, M., Muccioli, G. G., Delzenne, N. M., et al. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1219451110 · Cited by 4,511 · cited 1×
“On the other hand, participants with lower fecal SCFA excretion had a diverse microbiome, enriched in beneficial microbes including Akkermansia muciniphila, a taxon involved in maintaining the integrity of the mucin layer [50]; Christensenellaceae, Methanobrevibacter and Oscillospira, taxa associated with lower BMI [5…”
Background
Research works printed but not linked: 1
- (2017, June 01). IPAQ Research Committee Guidelines for Data Processing and Analysis of the International Physical Activity Questionnaire (IPAQ): Short and Long Forms. Available online: http://www.academia.edu/5346814/Guidelines_for_Data_Processing_and_Analysis_of_the_International_Physical_Activity_Questionnaire_IPAQ_Short_and_Long_Forms_Contents.
Cited by
Items 101–200 of 556
Adipokines and Adipose Tissue-Related Metabolites, Nuts and Cardiovascular Disease
Weschenfelder, C., de Quadros, A. S., dos Santos, J. L., Garofallo, S. B., & Marcadenti, A. (2020) · Metabolites · doi:10.3390/metabo10010032 · Cited by 59
Sleep and circadian disruption and the gut microbiome-possible links to dysregulated metabolism
Withrow, D., Bowers, S. J., Depner, C. M., González, A., Reynolds, A. C., & Wright, K. P. (2020) · Current Opinion in Endocrine and Metabolic Research · doi:10.1016/j.coemr.2020.11.009 · Cited by 60
Roles of gut microbiota and metabolites in overweight and obesity of children
Zhang, S., & Dang, Y. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.994930 · Cited by 70
“A decrease in butyrate-producing strains in obese children has been observed (83), and fecal butyrate concentration is negatively related to gut microbiota diversity, which also affects intestinal permeability (102).”
BackgroundRen, T., Liu, F., Wang, D., Li, B., Jiang, P., Li, J., Li, H., Chen, C., Wu, W. H., & Jiao, L. (2022) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2022.115862 · Cited by 60
Gut microbiota short-chain fatty acids and their impact on the host thyroid function and diseases
Mendoza-León, M. J., Mangalam, A. K., Regaldiz, A., González-Madrid, E., Rangel-Ramírez, M. A., Álvarez-Mardones, O., Vallejos, O. P., Méndez, C., Bueno, S. M., Melo-González, F., et al. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1192216 · Cited by 63
Thing, M., Werge, M. P., Kimer, N., Hetland, L. E., Rashu, E. B., Nabilou, P., Junker, A. E., Galsgaard, E. D., Bendtsen, F., Laupsa‐Borge, J., et al. (2024) · BMC Gastroenterology · doi:10.1186/s12876-024-03129-7 · Cited by 60
Dione, N., Lacroix, S., Taschler, U., Deschênes, T., Abolghasemi, A., Leblanc, N., Di Marzo, V., & Silvestri, C. (2020) · Cells · doi:10.3390/cells9122705 · Cited by 52
“As expected, HFD feeding reduced fecal SCFA levels; however, there was no difference between WT and Mgll−/− on either diet and no fecal SCFAs have been found to associate with healthful metabolic parameters, such as insulin sensitivity [57], while fecal levels have been correlated with obesity and cardiovascular risk…”
Huang, M., Zhao, Q., Duan, R., Liu, Y., & Wan, Y. (2021) · Environmental Pollution · doi:10.1016/j.envpol.2021.117702 · Cited by 56
The change of gut microbiota‐derived short‐chain fatty acids in diabetic kidney disease
Zhong, C., Dai, Z., Chai, L., Wu, L., Li, J., Guo, W.-Y., Zhang, J., Zhang, Q., Xue, C., Lin, H., et al. (2021) · Journal of Clinical Laboratory Analysis · doi:10.1002/jcla.24062 · Cited by 58
Caro-Gómez, E., Sierra, J. A., Escobar, J. S., Álvarez, R., Naranjo, M., Medina, S., Velásquez-Mejía, E. P., Tabares-Guevara, J. H., Jaramillo, J. C., León-Varela, Y. M., et al. (2019) · Nutrients · doi:10.3390/nu11030497 · Cited by 59
“Among the latter, Lactococcus and Lachnospiraceae have been shown increased in studies with mice treated with HFDs [101,102], while Streptococcus and Clostridiaceae SMB53 are increased in human individuals with obesity and metabolic dysregulation [103].”
Self-citationTargeting Gut Microbiota to Treat Hypertension: A Systematic Review
Palmu, J., Lahti, L., & Niiranen, T. (2021) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph18031248 · Cited by 61
“de la Cuesta-Zuluaga [34] 441 subjects in Colombia 16S rRNA (V4) Increased fecal acetate, propionate, and butyrate”
BackgroundSobh, M., Montroy, J. R., Daham, Z., Sibbald, S., Lalu, M. M., Stintzi, A., Mack, D. R., & Fergusson, D. A. (2021) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/nqab402 · Cited by 58
Yu, S., Wang, L., Jing, X., Wang, Y., & An, C. (2023) · Frontiers in Psychology · doi:10.3389/fpsyg.2023.1088268 · Cited by 55
Wang, X., Xu, M., Xu, D., Ma, K., Zhang, C., Wang, G., Dong, M., & Li, W. (2022) · Carbohydrate Polymers · doi:10.1016/j.carbpol.2022.119971 · Cited by 53
Kaczmarczyk, O., Dąbek, A., Woźniakiewicz, M., Paśko, P., Dobrowolska‐Iwanek, J., Woźniakiewicz, A., Piątek-Guziewicz, A., Zagrodzki, P., Mach, T., & Zwolinska-Wcislo, M. M. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10204701 · Cited by 55
Regulatory effect of gut microbes on blood pressure
Yan, D., Sun, Y. Q., Zhou, X., Si, W., Liu, J., Li, M., & Wu, M. (2022) · Animal Models and Experimental Medicine · doi:10.1002/ame2.12233 · Cited by 51
Review of the Relationships Between Human Gut Microbiome, Diet, and Obesity
Patloka, O., Komprda, T., & Franke, G. (2024) · Nutrients · doi:10.3390/nu16233996 · Cited by 55
“Additionally, serum and plasma levels of propionate and butyrate may be reduced in individuals with a higher BMI [76,77].”
Galié, S., García-Gavilán, J. F., Camacho‐Barcia, L., Atzeni, A., Muralidharan, J., Papandreou, C., Arcelin, P., Galindo, A. P., Garcia, D., Basora, J., et al. (2021) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.202000982 · Cited by 57
Huang, H., Lin, Y., Panyod, S., Chen, R.-A., Lin, Y., Chai, L. M. X., Hsu, C., Wu, W., Lu, K., Huang, Y., et al. (2022) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2022.115872 · Cited by 48
Stool Short-Chain Fatty Acids in Critically Ill Patients with Sepsis
Valdés-Duque, B. E., Giraldo, N. A. G., Jaillier-Ramírez, A. M., Villa, A. G., Acevedo-Castaño, I., Yepes-Molina, M. A., Barbosa-Barbosa, J., Barrera-Causil, C., & Agudelo, G. M. (2020) · Journal of the American College of Nutrition · doi:10.1080/07315724.2020.1727379 · Cited by 49
Sun, Y., Wang, F., Liu, Y., An, Y., Chang, D., Wang, J., Xia, F., Liu, N., Chen, X., & Cao, Y. (2022) · Food & Function · doi:10.1039/d1fo02944d · Cited by 49
Mezhibovsky, E., Knowles, K. A., He, Q., Sui, K., Tveter, K. M., Duran, R. M., & Roopchand, D. E. (2021) · Frontiers in Nutrition · doi:10.3389/fnut.2021.675267 · Cited by 52
“muciniphila relative abundance and fecal SCFA concentrations was reported (23).”
BackgroundNotarbartolo, V., Carta, M., Accomando, S., & Giuffrè, M. (2023) · Nutrients · doi:10.3390/nu15184014 · Cited by 53
“According to recent research, higher fecal concentrations of butyrate and propionate in adults may be related to worse metabolic outcomes; meanwhile, higher serum levels of SCFAs may be related to better health [74,75].”
BackgroundWang, Y., Wang, H., Howard, A. G., Meyer, K. A., Tsilimigras, M. C. B., Avery, C. L., Sha, W., Sun, S., Zhang, J., Su, C., et al. (2020) · Nutrients · doi:10.3390/nu12072127 · Cited by 48
The Gut/Lung Microbiome Axis in Obesity, Asthma, and Bariatric Surgery: A Literature Review
Kim, Y. J., Womble, J. T., Gunsch, C. K., & Ingram, J. L. (2021) · Obesity · doi:10.1002/oby.23107 · Cited by 47
Wang, X., Liu, F., Cui, Y., Yin, Y., Li, S., & Li, X. (2021) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.1c07258 · Cited by 47
Deledda, A., Palmas, V., Heidrich, V., Fosci, M., Lombardo, M., Cambarau, G., Lai, A., Melis, M., Loi, E., Loviselli, A., et al. (2022) · Metabolites · doi:10.3390/metabo12111092 · Cited by 55
Gut microbiota derived short‐chain fatty acids in physiology and pathology: An update
Archana, Gupta, A. K., Noumani, A., Panday, D. K., Zaidi, F., Sahu, G. K., Joshi, G., Yadav, M., Borah, S. J., Susmitha, V., et al. (2024) · Cell Biochemistry and Function · doi:10.1002/cbf.4108 · Cited by 46
“143,168 It was found that obese individuals have lower concentrations of propionate and butyrate in plasma when compared with lean individuals.”
A Role for Gut Microbiome Fermentative Pathways in Fatty Liver Disease Progression
Iruzubieta, P., Medina, J. M., Fernández-López, R., Crespo, J., & de la Cruz, F. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9051369 · Cited by 47
“On the other hand, higher fecal SCFA concentrations were found in genetically obese mice, and were associated with increased gut permeability, excess adiposity and cardiometabolic risk factors [7,70].”
BackgroundDi, S., Wang, Y., Han, L., Bao, Q. D., Gao, Z., Wang, Q., Yang, Y., Zhao, L., & Tong, X. (2019) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2019/2958920 · Cited by 46
Microbiome metabolite quantification methods enabling insights into human health and disease
Laro, J. A., Mital, R., Haffner, J. J., Colwell, N., Coats, R., Palacios, H. M., Liu, Z., Godinho, J. L. P., Ness, M., Peramuna, T., et al. (2024) · Methods · doi:10.1016/j.ymeth.2023.12.007 · Cited by 43
Intermittent Fasting Regulates Metabolic Homeostasis and Improves Cardiovascular Health
Diab, R., Dimachkie, L., Zein, O., Dakroub, A. H., & Eid, A. H. (2024) · Cell Biochemistry and Biophysics · doi:10.1007/s12013-024-01314-9 · Cited by 50
“However, the stabilization of HIF-1 remains the major mechanism by which SCFAs act [111].”
BackgroundGoal-oriented Analysis of Regulations.
Darimont, R., & Lemoine, M. (2006) · Cited by 47
Yadav, S. K., Ito, N., Mindur, J. E., Kumar, H., Youssef, M., Suresh, S., Kulkarni, R., Rosario, Y., Balashov, K. E., Dhib-Jalbut, S. S., et al. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.1015372 · Cited by 43
“Indeed, recent studies have also shown that increased fecal SCFA levels are associated with gut dysbiosis in metabolic diseases (59, 60).”
BackgroundDeng, Y., Liu, W., Wang, J., Yu, J. M., & Yang, L. (2020) · Medical Science Monitor · doi:10.12659/msm.926789 · Cited by 42
Goguyer‐Deschaumes, R., Waeckel, L., Killian, M., Rochereau, N., & Paul, S. (2021) · Trends in Immunology · doi:10.1016/j.it.2021.11.005 · Cited by 44
Gut microbiota and obesity: an overview of microbiota to microbial-based therapies
Sheykhsaran, E., Abbasi, A., Leylabadlo, H. E., Sadeghi, J., Mehri, S., Mazraeh, F. N., Feizi, H., & Baghi, H. B. (2022) · Postgraduate Medical Journal · doi:10.1136/postgradmedj-2021-141311 · Cited by 45
Łoniewska, B., Fraszczyk-Tousty, M., Tousty, P., Skonieczna‐Żydecka, K., Maciejewska, D., & Łoniewski, I. (2023) · Nutrients · doi:10.3390/nu15020367 · Cited by 43
Shum, B. J., & Georgia, S. K. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.625415 · Cited by 40
Liang, T., Xie, X., Wu, L., Li, L., Yang, L., Jiang, T., Du, M., Chen, M., Xue, L., Zhang, J., et al. (2023) · Food Chemistry · doi:10.1016/j.foodchem.2023.135412 · Cited by 39
Ju, X., Jiang, Z., Ma, J., & Yang, D. J. (2024) · Nutrients · doi:10.3390/nu16111727 · Cited by 41
“A diet low in FODMAPs is an effective intervention for IBS patients, while FMT or supplementary probiotics seem unhelpful for IBS patients.”
BackgroundJaimes, J. D. C., Slavíčková, A., Hurych, J., Cinek, O., Nichols, B., Vodolánová, L., Černý, K., & Havlík, J. (2021) · PLoS ONE · doi:10.1371/journal.pone.0247378 · Cited by 45
“Butyrate’s two positive correlations, with Haemophilus and Roseburia, are supported by several previous studies [7, 49, 50, 52].”
ResultMetabolic networks of the human gut microbiota
Selber‐Hnatiw, S., Sultana, T., Tse, W., Abdollahi, N., Abdullah, S., Rahbani, J. A., Alazar, D., Alrumhein, N. J., Aprikian, S., Arshad, R., et al. (2019) · Microbiology · doi:10.1099/mic.0.000853 · Cited by 41
The Characteristics, Mechanisms and Therapeutics: Exploring the Role of Gut Microbiota in Obesity
Zhuang, Z., Zhou, P., Wang, J., Lu, X., & Chen, Y. (2023) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s432344 · Cited by 38
Role of gut microbiota and derived metabolites in cardiovascular diseases
Yu, J., Yang, Y., Chen, W., Hu, J., Jin, Z., Wu, C., & Li, Y. (2025) · iScience · doi:10.1016/j.isci.2025.113247 · Cited by 40
“189 Moreover, the supplementation of propionate has been found to mitigate Ang II-induced hypertension in mouse models.”
Altered in Vitro Metabolomic Response of the Human Microbiota to Sweeteners
Vamanu, E., Pelinescu, D. R., Gatea, F., & Sârbu, I. (2019) · Genes · doi:10.3390/genes10070535 · Cited by 40
“The rise in the SCFAs post sweetener in vitro treatment has been linked to the stimulation of the in vivo transit [20].”
BackgroundGut bacteria formation and influencing factors
Yang, J., Wu, J., Li, Y., Zhang, Y., Cho, W. C. S., Ju, X., van Schothorst, E. M., & Zheng, Y. (2021) · FEMS Microbiology Ecology · doi:10.1093/femsec/fiab043 · Cited by 37
Turpin, T., Thouvenot, K., & Gonthier, M. (2023) · Biomolecules · doi:10.3390/biom13121692 · Cited by 37
“…have higher fecal SCFA concentrations than those measured in lean individuals, indicating that gut microbiota dysbiosis during obesity may lead to less e ffi cient SCFA absorption through the colonic barrier, and therefore may promote more microbial energy harvest and SCFA fecal excretion [163].”
BackgroundInfluentialUntapped potential of gut microbiome for hypertension management
Gao, K., Wang, P., Mei, X., Yang, T., & Yu, K. (2024) · Gut Microbes · doi:10.1080/19490976.2024.2356278 · Cited by 40
Li, M., Zhu, R., Song, X., Wang, Z., Weng, H., & Liang, J. (2020) · The Analyst · doi:10.1039/d0an00005a · Cited by 37
Dąbek, A., Kaczmarczyk, O., Woźniakiewicz, M., Paśko, P., Dobrowolska‐Iwanek, J., Woźniakiewicz, A., Piątek-Guziewicz, A., Zagrodzki, P., & Zwolinska-Wcislo, M. M. (2022) · Biology · doi:10.3390/biology11010108 · Cited by 35
“However, BCFAs appear to be produced by bacteria belonging to the genera Bacteroides and Clostridium, but the specific species responsible for their production are still unknown [39].”
BackgroundJin, J., Wang, J., Cheng, R., Ren, Y., Miao, Z., Luo, Y., Zhou, Q., Xue, Y., Shen, X. P., He, F., et al. (2022) · Frontiers in Microbiology · doi:10.3389/fmicb.2022.908327 · Cited by 36
“FBG, fasting blood glucose; OGTT, oral glucose tolerance test; TG, Triglyceride; TC, total cholesterol; LDL-C, low-density lipoprotein-cholesterol; HDL-C, high-density lipoprotein-cholesterol. a variety of physiologic processes or excreted in feces (de la Cuesta-Zuluaga et al., 2018).”
BackgroundPolyphenols–Gut–Heart: An Impactful Relationship to Improve Cardiovascular Diseases
Bianchi, F., Cappella, A., Gagliano, N., Sfondrini, L., & Stacchiotti, A. (2022) · Antioxidants · doi:10.3390/antiox11091700 · Cited by 38
Targeting gut-liver axis by dietary lignans ameliorate obesity: evidences and mechanisms
Chu, Z., Hu, Z., Luo, Y., Zhou, Y., Yang, F., & Luo, F. (2023) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2023.2272269 · Cited by 37
“Higher SCFA concentrations are linked to indicators of metabolic diseases, intestinal permeability, obesity, and hypertension (Sze et al. 2019; de la Cuesta-Zuluaga et al. 2018).”
The Role of Gut Microbiota in the Onset and Progression of Obesity and Associated Comorbidities
Enache, R. M., Profir, M., Roşu, O. A., Creţoiu, S. M., & Gașpar, B. S. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms252212321 · Cited by 38
Sun, Q. H., Liu, Z. J., Zhang, L., Wei, H., Song, L. J., Zhu, S. W., He, M. B., & Duan, L. (2021) · Journal of Digestive Diseases · doi:10.1111/1751-2980.12988 · Cited by 38
Huang, Y., Lou, X., Jiang, C., Ji, X., Tao, X., Sun, J., & Bao, Z. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.1044030 · Cited by 35
Liu, B., Yu, L., Zhai, Q., Li, M., Li, L., Tian, F., & Chen, W. (2023) · Food & Function · doi:10.1039/d3fo00574g · Cited by 36
Mohsenzadeh, A., Pourasgar, S., Mohammadi, A., Nazari, M., Nematollahi, S., Karimi, Y., Firoozbakhsh, P., Mohsenzadeh, H., Kamali, K., & Elahi, R. (2025) · Life Sciences · doi:10.1016/j.lfs.2025.123981 · Cited by 36
Genomic Determinants of Hypertension With a Focus on Metabolomics and the Gut Microbiome
Louca, P., Menni, C., & Padmanabhan, S. (2020) · American Journal of Hypertension · doi:10.1093/ajh/hpaa022 · Cited by 34
Miah, P., Mohona, S. B. S., Rahman, M. M., Subhan, N., Khan, F., Hossain, H., Sharker, S. M., & Alam, M. A. (2021) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2021.111908 · Cited by 38
Luo, L., Chang, Y., & Li, S. (2023) · Life Sciences · doi:10.1016/j.lfs.2023.121614 · Cited by 34
Gut microbiota: a potential new regulator of hypertension
Ge, Y., Wang, J., Wu, L., & Wu, J. (2024) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2024.1333005 · Cited by 36
Early Nutrition and Risk of Type 1 Diabetes: The Role of Gut Microbiota
Verduci, E., Mameli, C., Amatruda, M., Petitti, A., Vizzuso, S., Assadi, F. E., Zuccotti, G., Alabduljabbar, S., & Terranegra, A. (2020) · Frontiers in Nutrition · doi:10.3389/fnut.2020.612377 · Cited by 37
It takes guts to learn: machine learning techniques for disease detection from the gut microbiome
Curry, K. D., Nute, M., & Treangen, T. J. (2021) · Emerging Topics in Life Sciences · doi:10.1042/etls20210213 · Cited by 35
Gut macrobiotic and its metabolic pathways modulate cardiovascular disease
Zhu, J., Lyu, J., Zhao, R., Liu, G., & Wang, S. (2023) · Frontiers in Microbiology · doi:10.3389/fmicb.2023.1272479 · Cited by 37
The role of gut dysbiosis-associated inflammation in heart failure
Francisqueti‐Ferron, F. V., Nakandakare-Maia, E. T., Siqueira, J. S., Ferron, A. J. T., Vieira, T. A., Bazan, S. G. Z., & Corrêa, C. R. (2022) · Revista da Associação Médica Brasileira · doi:10.1590/1806-9282.20220197 · Cited by 31
Yin, P., Du, T., Yi, S., Zhang, C., Yu, L., Tian, F., Chen, W., & Zhai, Q. (2023) · Food Research International · doi:10.1016/j.foodres.2023.113598 · Cited by 31
Impact of Extreme Obesity and Diet‐Induced Weight Loss on the Fecal Metabolome and Gut Microbiota
Nogacka, A. M., Reyes‐Gavilán, C. G. D. L., Faedo, C. M., Ruas‐Madiedo, P., Suárez, A., Mancabelli, L., Ventura, M., Cifuentes, A., León, C., Gueimonde, M., et al. (2020) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.202000030 · Cited by 31
Sick Individuals and Sick (Microbial) Populations: Challenges in Epidemiology and the Microbiome
Renson, A., Herd, P., & Dowd, J. B. (2019) · Annual Review of Public Health · doi:10.1146/annurev-publhealth-040119-094423 · Cited by 34
“Some studies (n = 8) adjusted for diet in some way (9, 25, 33, 68, 71, 101, 120, 133).”
BackgroundInfluence of Age, Sex, and Diet on the Human Fecal Metabolome Investigated by 1H NMR Spectroscopy
Cui, M., Trimigno, A., Aru, V., Rasmussen, M. A., Khakimov, B., & Engelsen, S. B. (2021) · Journal of Proteome Research · doi:10.1021/acs.jproteome.1c00220 · Cited by 30
The Bidirectional Signal Communication of Microbiota‐Gut‐Brain Axis in Hypertension
Wang, X., Chen, Z., Geng, B., & Cai, J. (2021) · International Journal of Hypertension · doi:10.1155/2021/8174789 · Cited by 30
Egea, M. B., Filho, J. G. D. O., & Lemes, A. C. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241512015 · Cited by 35
Therapeutic applications of gut microbes in cardiometabolic diseases: current state and perspectives
Yuan, L., Li, Y., Chen, M., Xue, L., Wang, J., Ding, Y., Gu, Q., Zhang, J., Zhao, H., Xie, X., et al. (2024) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-024-13007-7 · Cited by 30
“Most studies have found that the gut microbiota of patients with hypertension was identified a reduced alpha diversity (De la Cuesta-Zuluaga et al. 2018; Jackson et al. 2018; Sun et al. 2019; Verhaar et al. 2020).”
Zhuang, T., Li, W., Yang, L., Wang, Z., Ding, L., & Zhou, M. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.731288 · Cited by 30
“They also serve an important role in the obesity process by regulating triglycerides, adipocyte differentiation, and leptin expression (Tan et al., 2014; De la Cuesta-Zuluaga et al., 2019; Jiao et al., 2020).”
BackgroundBurton, T. C. J., Lv, N., Tsai, P., Bernabé, B. P., Tussing-Humphreys, L. M., Xiao, L., Pandey, G. N., Wu, Y., Ajilore, O., & Ma, J. (2023) · American Journal of Clinical Nutrition · doi:10.1016/j.ajcnut.2023.01.018 · Cited by 31
Role of gut microbial metabolites in nonalcoholic fatty liver disease
Zhao, Z. H., Lai, J. K., Qiao, L., & Fan, J. (2019) · Journal of Digestive Diseases · doi:10.1111/1751-2980.12709 · Cited by 30
“A community-based study of an adult group has reported that fecal SCFA concentrations are positively associated with evidence of gut dysbiosis, gut permeability, excess adiposity, and cardiometabolic risk factors.(22) On the other hand, it has also been shown that a deficiency in SCFA production is associated with typ…”
BackgroundDubiński, P., Czarzasta, K., & Cudnoch‐Jędrzejewska, A. (2021) · Current Hypertension Reports · doi:10.1007/s11906-021-01144-7 · Cited by 27
Logan, I. E., Shulzhenko, N., Sharpton, T. J., Bobe, G., Liu, K., Nuss, S., Jones, M. L., Miranda, C. L., Vasquez‐Perez, S., Pennington, J. M., et al. (2021) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.202100389 · Cited by 30
Bui, T. I., Britt, E. A., Muthukrishnan, G., & Gill, S. R. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.1094258 · Cited by 28
Obesity is the main driver of altered gut microbiome functions in the metabolically unhealthy
de la Cuesta‐Zuluaga, J., Huus, K. E., Youngblut, N. D., Escobar, J. S., & Ley, R. E. (2023) · Gut Microbes · doi:10.1080/19490976.2023.2246634 · Cited by 30
Self-citationColaci, C., Gambardella, M. L., Scarlata, G. G. M., Boccuto, L., Colica, C., Luzza, F., Scarpellini, E., Méndez‐Sánchez, N., & Abenavoli, L. (2024) · Hepatoma Research · doi:10.20517/2394-5079.2023.134 · Cited by 27
Continuing cereals research for sustainable health and well-being
Poole, N., Donovan, J., & Erenstein, O. (2021) · International Journal of Agricultural Sustainability · doi:10.1080/14735903.2021.1975437 · Cited by 29
Guzmán-Castañeda, S. J., Ortega-Vega, E. L., de la Cuesta‐Zuluaga, J., Velásquez-Mejía, E. P., Rojas, W., Bedoya, G., & Escobar, J. S. (2019) · Gut Microbes · doi:10.1080/19490976.2019.1634416 · Cited by 31
Self-citationSample Preparation Methods for Lipidomics Approaches Used in Studies of Obesity
Liakh, I., Śledziński, T., Kaska, Ł., Mozolewska, P., & Mika, A. (2020) · Molecules · doi:10.3390/molecules25225307 · Cited by 28
Stø, K., Valeur, J., Ueland, T., Malmstrøm, G. H., Bjerkeli, V., Trøseid, M., Hov, J. R., Holm, K., Vestad, B., Halvorsen, B. L., et al. (2022) · Scientific Reports · doi:10.1038/s41598-022-26759-x · Cited by 28
Li, J., Xing, H., Lin, W., Yu, H., Yang, B., Jiang, C., Zhang, J., Wu, R., Ding, F., Pei, M., et al. (2024) · Frontiers in Medicine · doi:10.3389/fmed.2023.1302352 · Cited by 29
“Some studies believed that SCFAs played a beneficial role in regulating lipid metabolism disorders (70, 71), but some studies also found that higher SCFAs were associated with central obesity and dyslipidemia (72).”
Resultda Silva, T. R., Marchesan, L. B., Rampelotto, P. H., Longo, L., de Oliveira, T. F., Landberg, R., de Mello, V. D., & Spritzer, P. M. (2024) · Journal of Ovarian Research · doi:10.1186/s13048-024-01550-w · Cited by 31
Kasti, A. N., Katsas, K., Pavlidis, D., Stylianakis, E., Petsis, K., Lambrinou, S., Nikolaki, M. D., Papanikolaou, I. S., Hatziagelaki, E. E., Papadimitriou, K., et al. (2025) · Nutrients · doi:10.3390/nu17091545 · Cited by 28
“This aligns with previous research indicating that SCFA levels correlate with symptom severity in IBS with diarrhea [12,37,88,89].”
Thomas, A., Thomas, A., & Butler-Sanchez, M. (2021) · American Journal of Lifestyle Medicine · doi:10.1177/15598276211012968 · Cited by 28
Rahman, M. N., Diantini, A., Fattah, M., Barliana, M. I., & Wijaya, A. (2021) · Analytical and Bioanalytical Chemistry · doi:10.1007/s00216-021-03639-3 · Cited by 29
“The underlying mechanism begins with gut microbiota dysbiosis, which is caused by both an imbalance in SCFA production and gut permeability alteration [9].”
BackgroundNavalon-Monllor, V., Soriano-Romaní, L., Silva, M., Hazas, M. L. D. L., Hernando-Quintana, N., Suárez-Diéguez, T., Morell, P., & Nieto, J. A. (2023) · Food & Function · doi:10.1039/d3fo01257c · Cited by 25
Using Gut Microbiota Modulation as a Precision Strategy Against Obesity
Baek, K.-R., Singh, S., Hwang, H.-S., & Seo, S. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26136282 · Cited by 24
Biomarkers of Human Gut Microbiota Diversity and Dysbiosis
Rüb, A., Tsakmaklis, A., Gräfe, S. K., Simon, M., Vehreschild, M. J. G. T., & Wüthrich, I. (2021) · Biomarkers in Medicine · doi:10.2217/bmm-2020-0353 · Cited by 26
Shaoyong, W., Zhang, W., Wang, C., Kou, Z., Yong, W., Jiao, J., Yan, W., & Pang, W. (2021) · The Science of The Total Environment · doi:10.1016/j.scitotenv.2021.146018 · Cited by 24
Multi-organ Coordination of Lipoprotein Secretion by Hormones, Nutrients and Neural Networks
Stahel, P., Xiao, C., Nahmias, A., Tian, L., & Lewis, G. F. (2021) · Endocrine Reviews · doi:10.1210/endrev/bnab008 · Cited by 26
Smith, C. A., Haute, M. J. S. V., Xian, Y., Muñoz, R. R. S., Liu, S., Schmaltz, R. J., Ramer‐Tait, A. E., & Rose, D. J. (2022) · Gut Microbes · doi:10.1080/19490976.2022.2126275 · Cited by 25
Jian, Y., Cheng, L., Hong, Y., Li, Z., Li, C., Ban, X., Zhu, L., & Gu, Z. (2023) · Nutrients · doi:10.3390/nu15245080 · Cited by 26
“It is reported that the gut microbiota has significant effects on gut permeability [66] and blood brain barrier (BBB) integrity [67].”
BackgroundBoyajian, J. L., Islam, P., Abosalha, A. K., Schaly, S., Thareja, R., Kassab, A., Arora, K., Santos, M., Shum-Tim, C., & Prakash, S. (2024) · Microbiome Research Reports · doi:10.20517/mrr.2024.05 · Cited by 30
Tortelote, G. G. (2025) · Pediatric Nephrology · doi:10.1007/s00467-025-06883-2 · Cited by 25
“The phylum Firmicutes includes many known SCFA producers [19, 37, 125].”
Metadata
- Authors
- De la Cuesta-Zuluaga, J., Mueller, N., Álvarez-Quintero, R., Velásquez-Mejía, E., Sierra, J., Corrales-Agudelo, V., Carmona, J., Abad, J., & Escobar, J.
- Affiliations
- Vidarium–Nutrition, Health and Wellness Research Center, Grupo Empresarial Nutresa, Calle 8 sur #50-67, 050023 Medellin, Colombia
- Johns Hopkins University (US)
- Grupo de Investigación en Sustancias Bioactivas, Sede de Investigación Universitaria (SIU), Universidad de Antioquia, Calle 62 #52-59, 050010 Medellin, Colombia
- Vidarium - Centro de Investigación en Nutrición Salud y Bienestar (CO)
- Dinámica IPS, Especialista en Ayudas Diagnósticas, Calle 27 #45-109, 050021 Medellin, Colombia
- EPS SURA, Calle 49A #63-55, 050034 Medellin, Colombia
- Corresponding author
- Escobar, Juan
- Venue
- Nutrients
- Publisher
- MDPI AG
- Published
- 2018-12-27
- Volume
- 11
- Issue
- 1
- Pages
- 51
- ISSN
- 2072-6643 (ISSN-L)
- PMC
- PMC6356834
- OpenAlex
- W2908425894
- Semantic Scholar
- 5eb68bb6bfbbdde0888adeae7373bb6a65842f51
- Cited by
- 533
- References
- 55
- Citations by year
- 2026: 43 · 2025: 61 · 2024: 85 · 2023: 82 · 2022: 81 · 2021: 91 · 2020: 58 · 2019: 31
- FWCI
- 16.00
- Type
- journal article
- Language
- en
- Open access
- gold
- dx.doi.org
- Licence
- Locations
- Nutrients (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- National Heart, Lung, and Blood Institute (K01HL141589)
- Mid-Atlantic Nutrition Obesity Research Center (P30DK072488)
- Foundation for Gender Specific Medicine (NA)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Nutritional Studies and Diet
- Health Sciences › Medicine › Gastroenterology › Gastrointestinal motility and disorders
- Keywords
- short-chain fatty acids, fecal SCFA, gut dysbiosis, microbiome diversity, intestinal permeability, obesity, hypertension, cardiometabolic risk factors, dietary fiber fermentation, acetate, butyrate, propionate
- MeSH terms
- Gastrointestinal Microbiome, Adolescent, Adult, Cardiovascular Diseases, Fatty Acids, Volatile, Feces, Female, Humans, Hypertension, Male, Metabolic Diseases, Middle Aged, Obesity, Young Adult
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.